Pay to Marwadi

Company Profile

MUTHOOT FINANCE LTD.

NSE : MUTHOOTFINBSE : 533398ISIN CODE : INE414G01012Industry : Finance - NBFCHouse : Muthoot
BSE1703.1024.25 (+1.44 % )
PREV CLOSE (Rs.) 1678.85
OPEN PRICE (Rs.) 1656.05
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 146
TODAY'S LOW / HIGH (Rs.)1656.05 1705.25
52 WK LOW / HIGH (Rs.)1022.9 1753
NSE1703.40 23.85 (+1.42 % )
PREV CLOSE(Rs.) 1679.55
OPEN PRICE (Rs.) 1694.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1703.40 (117 )
VOLUME 32687
TODAY'S LOW / HIGH(Rs.) 1684.05 1715.45
52 WK LOW / HIGH (Rs.)1022.5 1753.9

Company News

Date Heading Details
08-May-2024 Muthoot Finance informs about outcome of finance committee meet <p style="text-align: justify;">In furtherance of its letter dated April 18, 2024, Muthoot Finance has informed that the Finance Committee of the Board of Directors of the Company at its meeting held on May 07, 2024, has approved the pricing, tenure and other terms of the Notes under the GMTN Programme (the ‘Issue'). The proceeds of the Notes will be used by the Company for onward lending activities as may be permitted in accordance with the Foreign Exchange Management (Borrowing and Lending) Regulations 2018, the circulars issued thereunder by the Reserve Bank of India (‘RBI'), Master Direction – External Commercial Borrowings, Trade Credits and Structured Obligations dated March 26, 2019 (‘ECB Guidelines'), each as amended, and the approvals granted by the RBI from time to time in this relation, and in accordance with the ECB Guidelines and other applicable law, and any other instructions issued by RBI in this regard. The Company has signed the pricing supplement in this regard on May 07, 2024 and the details of the same are contained in Annexure A. The Company shall make the relevant intimations once the closing and settlement of the Notes are completed. Notes are proposed to be listed on NSE IFSC. The meeting commenced at 10:30 pm (IST) and concluded at 10:45 pm (IST).</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p><div style="text-align: justify;"><br></div>
26-Mar-2024 Reply To Clarification Sought On Increase In Volume - Muthoot Finance Limited Reply to Clarification sought on Increase in Volume - Muthoot Finance Limited
23-Mar-2024 Muthoot Finance reply to clarification sought on increase in volume <div style="text-align: justify;">In receipt of email dated March 06, 2024 regarding Increase in Volume, Muthoot Finance has informed that they were not aware of any specific reasons for significant increase in volume. To the best of knowledge, there were no pending announcements to be made to the exchange which might had a bearing on the price/ volume.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div>
21-Mar-2024 Muthoot Finance informs about acquisition <p style="text-align: justify;">In continuation of intimation dated February 14, 2024 regarding the decision of the Board to acquire an additional stake in Belstar Microfinance (Subsidiary), Muthoot Finance has informed that the acquisition of 4.48% equity stake in the Subsidiary through off-market acquisition from the Promoters is now completed. Details as required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 is given in Annexure A.</p><div>The above information is a part of company's filings submitted to BSE.</div>
06-Mar-2024 Clarification Sought from Muthoot Finance Ltd The Exchange has sought clarification from Muthoot Finance Ltd on March 6, 2024, with reference to Movement in Volume. The reply is awaited.
15-Feb-2024 Muthoot Finance gets nod for additional equity infusion of Rs 300 crore in Belstar Microfinance <p style="text-align: justify;">Muthoot Finance has received approval for additional equity infusion of Rs 300 crore in Belstar Microfinance, a subsidiary of the Company and secondary purchase of equity shares of Belstar from the existing promoters for a consideration of upto Rs 75 crore. Additional equity infusion is proposed to be made in order to strengthen the capital base and improve the capital adequacy ratio. Secondary acquisition from the promoters aids Muthoot Finance to increase its equity stake in Belstar. The Board of Directors of the company at their meeting held on February 14, 2024, has approved the same.&nbsp;</p><p style="text-align: justify;">Muthoot Finance is a non-banking financial company (NBFC), which is engaged in providing loan (financing) against collateral of gold jewelry. The company offers gold loans, foreign inward money transfer services, foreign exchange services, insurance broking etc.&nbsp;</p><div style="text-align: justify;"><br></div>
15-Feb-2024 Muthoot Finance gets nod to raise upto Rs 6,000 crore through NCDs <p style="text-align: justify;">Muthoot Finance has received approval to raise funds by issuance of Redeemable Non-Convertible Debentures (NCDs), through public issue, for an amount upto Rs 6,000 crore to be issued in one or more tranches as may be decided by the Board of Directors or a committee thereof from time to time.&nbsp;</p><p style="text-align: justify;">The company has also received approval to raise funds by issuance of Redeemable Non-Convertible Debentures, through public issue, for an amount upto Rs 10,000 crore to be issued in one or more tranches as may be decided by the Board of Directors or a committee thereof from time to time. The Board of Directors, at the meeting held on February 14, 2024 approved the same.&nbsp;</p><p style="text-align: justify;">Muthoot Finance is a non-banking financial company (NBFC), which is engaged in providing loan (financing) against collateral of gold jewelry. The company offers gold loans, foreign inward money transfer services, foreign exchange services, insurance broking etc.&nbsp;</p>
15-Feb-2024 Muthoot Finance soars on getting nod for additional equity infusion of Rs 300 crore in Belstar Microfinance <p style="text-align: justify;">Muthoot Finance is currently trading at Rs. 1438.30, up by 58.50 points or 4.24% from its previous closing of Rs. 1379.80 on the BSE.</p><p style="text-align: justify;">The scrip opened at Rs. 1402.05 and has touched a high and low of Rs. 1443.00 and Rs. 1402.05 respectively. So far 7595 shares were traded on the counter.</p><p style="text-align: justify;">The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1537.40 on 05-Jan-2024 and a 52 week low of Rs. 911.40 on 16-Mar-2023.</p><p style="text-align: justify;">Last one week high and low of the scrip stood at Rs. 1444.30 and Rs. 1345.25 respectively. The current market cap of the company is Rs. 55393.31 crore.</p><p style="text-align: justify;">The promoters holding in the company stood at 73.35%, while Institutions and Non-Institutions held 22.93% and 3.71% respectively.</p><p style="text-align: justify;">Muthoot Finance has received approval for additional equity infusion of Rs 300 crore in Belstar Microfinance, a subsidiary of the Company and secondary purchase of equity shares of Belstar from the existing promoters for a consideration of upto Rs 75 crore. Additional equity infusion is proposed to be made in order to strengthen the capital base and improve the capital adequacy ratio. Secondary acquisition from the promoters aids Muthoot Finance to increase its equity stake in Belstar. The Board of Directors of the company at their meeting held on February 14, 2024, has approved the same.&nbsp;</p><p style="text-align: justify;">Muthoot Finance is a non-banking financial company (NBFC), which is engaged in providing loan (financing) against collateral of gold jewelry. The company offers gold loans, foreign inward money transfer services, foreign exchange services, insurance broking etc.</p><div style="text-align: justify;"><br></div>
15-Feb-2024 Muthoot Finance, HDFC Life Insurance and GR Infraprojects to see some action today <p style="text-align: justify;"><b>Muthoot Finance</b>'s board has approved additional equity infusion of Rs 300 crore in Belstar Microfinance, a subsidiary of the Company and secondary purchase of equity shares of Belstar from the existing promoters for a consideration of upto Rs 75 crore. Additional equity infusion is proposed to be made in order to strengthen the capital base and improve the capital adequacy ratio. Secondary acquisition from the promoters aids Muthoot Finance to increase its equity stake in Belstar&nbsp;</p><p style="text-align: justify;"><b>HDFC Life Insurance Company</b> and Lokmanya Multipurpose Cooperative Society have entered into a corporate agency tie-up that would enable the latter to distribute life insurance products of HDFC Life to its customers. HDFC Life offers a wide range of life insurance products, designed to meet various life stage needs of individuals. Through this new partnership, the company could contribute further towards increasing life insurance penetration.&nbsp;&nbsp;</p><p style="text-align: justify;"><b>GR Infraprojects </b>has entered into Share Purchase agreement with REC Power Development and Consultancy (RECPDCL) for acquisition of Pochora Power Transmission, wholly owned subsidiary of RECPDCL. After this acquisition, Pachora Power Transmission has become wholly owned subsidiary company of G R Infraprojects. The equity shares of Pachora Power Transmission have been acquired at total consideration of Rs 6.55 crore.&nbsp;</p><p style="text-align: justify;"><b>Tata Consultancy Services</b> (TCS) and Conga, a global leader in Revenue Lifecycle Management solutions, have forged a strategic partnership to offer more customized and state-of-the-art solutions to enterprises. TCS is the inaugural partner of Conga's Elevated Partnership Program and will strategize with Conga on next-gen solutions and transformation opportunities for clients' end-to-end revenue lifecycle management systems.</p><p style="text-align: justify;"><b>Balaxi Pharmaceuticals</b>' wholly owned subsidiary -- Balaxi Global DMCC has incorporated a new Wholly Owned Subsidiary in Chile by the name Balaxi Pharmaceuticals Chile SPA. Consequent to the incorporation, Balaxi Pharmaceuticals Chile SPA has become a Wholly Owned Step-Down Subsidiary of the Company. The object of Balaxi Pharmaceuticals Chile SPA is distribution and marketing of all types of medicines and pharmaceutical products which is in line with the company's main objects. The acquisition is a part of Company's expansion plans.</p><p style="text-align: justify;"><b>Kanoria Chemicals &amp; Industries (</b>KCI) is planning to add additional production capacity of Hexamine with 18 MTPD in Ankleshwar, Gujarat. This new capacity at Ankleshwar will cater to growing demand in various sectors such as Phenolic Resins, Textile, Agrochemicals, Explosives, Pharmaceuticals, etc. in the region as well as the exports markets. This additional capacity will help the company for sustainable development and inclusive growth in line with the company's vision. Expansion is expected to be completed by December 2024.</p><p style="text-align: justify;"><b>Reliance Industries</b> (RIL) is reportedly in talks the Walt Disney Company, to buy 29.8 per cent stake in Tata Play. This move is seen as part of RIL's broader strategy to deepen its footprint in India's television distribution sector.&nbsp;</p><div style="text-align: justify;"><br></div>
27-Jan-2024 Muthoot Finance informs about newspaper advertisements <div style="text-align: justify;">Muthoot Finance has informed that it enclosed the copies of News Paper advertisements made with respect to transfer of shares to Investor Education and Protection Fund.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div>